Some HIV-infected patients in Uganda who self paid for their antiretroviral medications experienced interruptions in drug supply due to either financial demands or supply logistical disruptions. These treatment interruptions led to the development of resistance to antiretroviral medications in patients.
Access to antiretroviral therapy for advanced HIV infection in low- and middle-income countries continued to grow throughout 2006, with more than 2 million people living with HIV/AIDS receiving treatment in December 2006, a 54% increase over the 1.3 million people on treatment one year earlier in these countries.
A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying.
Researchers at the University of Pennsylvania School of Medicine have discovered that an enzyme produced by lung-infecting bacteria further shuts down a protein that is defective in cystic fibrosis patients.
Minnesota’s bill to protect seriously ill patients from arrest for using medical marijuana with a doctor’s recommendation cleared another critical milestone today as the Senate Health and Human Services Budget Division passed S.F. 345 ? the medical marijuana bill ? 6?4.
Indian government committed to providing second-line drugs free of cost to people who develop resistance to the existing treatment for HIV /AIDS.
Access to antiretroviral therapy for advanced HIV infection in low- and middle-income countries continued to grow throughout 2006, with more than two million people living with HIV/AIDS receiving treatment in December 2006, a 54 per cent increase over the 1.3 million people on treatment one year earlier in these countries.
More than two million people in low- and middle-income countries now receive HIV therapy. Efforts must increase significantly to increase access to HIV treatment and prevention.
The United States India Business Council (USIBC) has applauded the decision of Abbott to significantly reduce the cost of its life-saving drug, Kaletra (a protease inhibitor to treat HIV/AIDS), in 40 developing countries, including, India.
Amid growing concern about the accumulation of pharmaceutical and personal care products (PPCPs) in fish and other aquatic organisms, scientists in Texas are reporting development of the first method that can screen fish for several different groups of drugs at the same time.